| Patent application number | Description | Published |
|---|
| 20100189807 | Use of an ozone / oxygen mixture as a primary anticancer therapy via intraperitoneal insufflation - Head and neck squamous cell carcinomas (HNSCC) represent a group of metastasizing tumors with a high mortality rate in man and animals. Since the biomolecule ozone was found to inhibit growth of various carcinoma cells in vitro we here applied the highly aggressive and lethal VX2 carcinoma HNSCC tumor model of the New Zealand White rabbit to test whether ozone exerts anti-tumorous effects in vivo. Therapeutic insufflation of medical ozone/oxygen (O | 07-29-2010 |
| 20110006261 | USE OF AN OZONE/OXYGEN MIXTURE AS PRIMARY ANTICANCER THERAPY THROUGH INTRAPERITONEAL INSUFFLATION - Head and neck squamous cell carcinomas (HNSCC) represent a group of metastasizing tumors with a high mortality rate in man and animals. Since the biomolecule ozone was found to inhibit growth of various carcinoma cells in vitro we here applied the highly aggressive and lethal VX2 carcinoma HNSCC tumor model of the New Zealand White rabbit to test whether ozone exerts anti-tumorous effects in vivo. Therapeutic insufflation of medical ozone/oxygen (O | 01-13-2011 |
